Dubai Health Authority and The Royal Marsden Hospital Enhance Cooperation in Cancer Treatment Services

The Royal Marsden Delegation Visits Dubai Health

Dame Cally Palmer, the Chief Executive and National Cancer Director of NHS England, led a delegation from The Royal Marsden on a visit to Dubai Health. The purpose of the visit was to strengthen internationally recognized treatment pathways and advance knowledge in cancer care.

The tour began at Hamdan Bin Rashid Cancer Hospital, Dubai's first comprehensive cancer facility. The visit reaffirmed Dubai Health's commitment to the core value of 'Patient First' and its mission to deliver world-class cancer care. The delegation, which included Professor Nicholas van As, Chief Medical Officer, and Dr. Angela George, Clinical Director of Genomics, expressed enthusiasm about the collaboration. Dame Cally Palmer stated that the partnership aims to create a model of excellence in cancer care.

During the visit, the delegation met with Dr. Raja Easa Al Gurg, Chair of the hospital's Steering Committee, to discuss integrating medical innovations and global best practices into Dubai's healthcare system. Dr. Al Gurg emphasized the importance of international partnerships for establishing Dubai as a leading destination for specialized healthcare. She highlighted that philanthropic support through Al Jalila Foundation plays a crucial role in this endeavour.

The delegation also toured Al Jalila Children's Hospital and Majlis Al Amal, a centre for female cancer patients. The visit provided insights into Dubai's commitment to service excellence, particularly in the field of healthcare. Emirates Airline facilities were also part of the tour, showcasing Dubai's dedication to providing top-notch services.

Although the visit did not include any new discussions regarding integrating medical innovations and global best practices into Dubai's healthcare system, this was a topic of discussion in the delegation's previous meeting. The search results do not provide information about who supports globally recognized cancer treatment methods in Dubai and has established international partnerships through the Al Jalila Foundation.

Dr. Amer Sharif, CEO of Dubai Health, underscored the visit's role in strengthening internationally recognized treatment pathways. He expressed his gratitude for the collaboration and looked forward to future opportunities for knowledge exchange and innovation in cancer care.

In conclusion, the visit by The Royal Marsden delegation to Dubai Health reinforced the commitment to global collaboration in healthcare and reaffirmed Dubai's position as a leading destination for specialized healthcare, particularly in cancer care. The partnership between the two institutions is set to create a model of excellence in cancer care, contributing to Dubai's vision of becoming a global hub for healthcare innovation.

Dubai Health Authority and The Royal Marsden Hospital Enhance Cooperation in Cancer Treatment Services